Table 5.

Postoperative Outcomes in Transfemale Versus Cisfemale Augmentation

	Transfemale Augmentation	Cisfemale Augmentation	P
No. of patients	280	1,080
All-cause complications	5 (1.8%)	18 (1.6%)	0.890
Superficial surgical-site infection	0 (0%)	3 (0.3%)	0.377
Deep surgical-site infection	0 (0%)	1 (0.1%)	0.610
Wound dehiscence	0 (0%)	2 (0.2%)	0.471
Deep vein thrombosis	0 (0%)	0 (0%)
Pulmonary embolism	0 (0%)	1 (0.1%)	0.610
Urinary tract infection	1 (0.4%)	2 (0.2%)	0.585
Unplanned reoperation	4 (1.4%)	10 (0.9%)	0.558
Unplanned readmission	4 (1.4%)	5 (0.5%)	0.076